SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-045154
Filing Date
2021-02-16
Accepted
2021-02-16 17:03:53
Documents
1
Group Members
FLAGSHIP V VENTURELABS RX FUND, L.P.FLAGSHIP VENTURELABS IV LLCFLAGSHIP VENTURES FUND IV, L.P.FLAGSHIP VENTURES FUND IV-RX, L.P.FLAGSHIP VENTURES FUND V GENERAL PARTNER LLCFLAGSHIP VENTURES FUND V, L.P.FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d123833dsc13ga.htm SC 13G/A 167323
  Complete submission text file 0001193125-21-045154.txt   169320
Mailing Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund IV General Partner LLC (Filed by) CIK: 0001508051 (see all company filings)

IRS No.: 352390209 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Subject) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90775 | Film No.: 21640556
SIC: 2836 Biological Products, (No Diagnostic Substances)